Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Chronic peripheral inflammation, hippocampal neurogenesis, and behavior.

Chesnokova V, Pechnick RN, Wawrowsky K.

Brain Behav Immun. 2016 Nov;58:1-8. doi: 10.1016/j.bbi.2016.01.017. Epub 2016 Jan 21. Review.

2.

New Signaling Pathway for Gut-Brain Interactions.

Chesnokova V, Pechnick RN.

Neuropsychopharmacology. 2016 Jan;41(1):372-3. doi: 10.1038/npp.2015.237. Review. No abstract available.

3.

Chronic intestinal inflammation alters hippocampal neurogenesis.

Zonis S, Pechnick RN, Ljubimov VA, Mahgerefteh M, Wawrowsky K, Michelsen KS, Chesnokova V.

J Neuroinflammation. 2015 Apr 3;12:65. doi: 10.1186/s12974-015-0281-0.

4.

p21Cip restrains hippocampal neurogenesis and protects neuronal progenitors from apoptosis during acute systemic inflammation.

Zonis S, Ljubimov VA, Mahgerefteh M, Pechnick RN, Wawrowsky K, Chesnokova V.

Hippocampus. 2013 Dec;23(12):1383-94. doi: 10.1002/hipo.22192. Epub 2013 Sep 18.

5.

A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.

Cohen RM, Rezai-Zadeh K, Weitz TM, Rentsendorj A, Gate D, Spivak I, Bholat Y, Vasilevko V, Glabe CG, Breunig JJ, Rakic P, Davtyan H, Agadjanyan MG, Kepe V, Barrio JR, Bannykh S, Szekely CA, Pechnick RN, Town T.

J Neurosci. 2013 Apr 10;33(15):6245-56. doi: 10.1523/JNEUROSCI.3672-12.2013.

6.

Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma.

Puntel M, A K M GM, Farrokhi C, Vanderveen N, Paran C, Appelhans A, Kroeger KM, Salem A, Lacayo L, Pechnick RN, Kelson KR, Kaur S, Kennedy S, Palmer D, Ng P, Liu C, Krasinkiewicz J, Lowenstein PR, Castro MG.

Toxicol Appl Pharmacol. 2013 May 1;268(3):318-30. doi: 10.1016/j.taap.2013.02.001. Epub 2013 Feb 9.

7.

Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trial.

Muhammad AK, Xiong W, Puntel M, Farrokhi C, Kroeger KM, Salem A, Lacayo L, Pechnick RN, Kelson KR, Palmer D, Ng P, Liu C, Lowenstein PR, Castro MG.

Hum Gene Ther Methods. 2012 Aug;23(4):271-84. doi: 10.1089/hgtb.2012.060. Epub 2012 Sep 5.

8.

Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus.

Pechnick RN, Zonis S, Wawrowsky K, Cosgayon R, Farrokhi C, Lacayo L, Chesnokova V.

PLoS One. 2011;6(11):e27290. doi: 10.1371/journal.pone.0027290. Epub 2011 Nov 4.

9.

Eszopiclone stimulates the hypothalamo-pituitary-adrenal axis in the rat.

Pechnick RN, Lacayo LM, Manalo CM, Bholat Y, Spivak I.

Eur J Pharmacol. 2011 Jul 1;661(1-3):22-6. doi: 10.1016/j.ejphar.2011.04.016. Epub 2011 Apr 29.

PMID:
21540024
10.

Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.

Pechnick RN, Manalo CM, Lacayo LM, Vit JP, Bholat Y, Spivak I, Reyes KC, Farrokhi C.

Behav Pharmacol. 2011 Jun;22(3):222-7. doi: 10.1097/FBP.0b013e328345f72c.

PMID:
21522053
11.

Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology.

Larocque D, Sanderson NS, Bergeron J, Curtin JF, Girton J, Wibowo M, Bondale N, Kroeger KM, Yang J, Lacayo LM, Reyes KC, Farrokhi C, Pechnick RN, Castro MG, Lowenstein PR.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14443-8. doi: 10.1073/pnas.0913496107. Epub 2010 Jul 26.

12.

A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics.

Puntel M, Muhammad AK, Candolfi M, Salem A, Yagiz K, Farrokhi C, Kroeger KM, Xiong W, Curtin JF, Liu C, Bondale NS, Lerner J, Pechnick RN, Palmer D, Ng P, Lowenstein PR, Castro MG.

J Virol. 2010 Jun;84(12):6007-17. doi: 10.1128/JVI.00398-10. Epub 2010 Apr 7.

13.

Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma.

Muhammad AK, Puntel M, Candolfi M, Salem A, Yagiz K, Farrokhi C, Kroeger KM, Xiong W, Curtin JF, Liu C, Lawrence K, Bondale NS, Lerner J, Baker GJ, Foulad D, Pechnick RN, Palmer D, Ng P, Lowenstein PR, Castro MG.

Clin Pharmacol Ther. 2010 Aug;88(2):204-13. doi: 10.1038/clpt.2009.260. Epub 2010 Feb 17.

14.

The role of dopaminergic agents in improving quality of life in major depressive disorder.

IsHak WW, Davis M, Jeffrey J, Balayan K, Pechnick RN, Bagot K, Rapaport MH.

Curr Psychiatry Rep. 2009 Dec;11(6):503-8. Review.

PMID:
19909674
15.

Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.

Candolfi M, Kroeger KM, Muhammad AK, Yagiz K, Farrokhi C, Pechnick RN, Lowenstein PR, Castro MG.

Curr Gene Ther. 2009 Oct;9(5):409-21. Review.

16.

Adult neurogenesis, cell cycle and drug discovery in psychiatry.

Pechnick RN, Chesnokova V.

Neuropsychopharmacology. 2009 Jan;34(1):244. doi: 10.1038/npp.2008.164. Review. No abstract available.

17.

Antidepressants and Cdk inhibitors: releasing the brake on neurogenesis?

Chesnokova V, Pechnick RN.

Cell Cycle. 2008 Aug;7(15):2321-6. Epub 2008 Jun 17. Review.

18.

Flt3L in Combination With HSV1-TK-mediated Gene Therapy Reverses Brain Tumor-induced Behavioral Deficits.

King GD, Kroeger KM, Bresee CJ, Candolfi M, Liu C, Manalo CM, Muhammad AG, Pechnick RN, Lowenstein PR, Castro MG.

Mol Ther. 2008 Apr;16(4):682-690. doi: 10.1038/mt.2008.18. Epub 2016 Dec 8.

PMID:
28178463
19.

Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits.

King GD, Kroeger KM, Bresee CJ, Candolfi M, Liu C, Manalo CM, Muhammad AK, Pechnick RN, Lowenstein PR, Castro MG.

Mol Ther. 2008 Apr;16(4):682-90. doi: 10.1038/mt.2008.18. Epub 2008 Feb 19.

20.

Comparison of the effects of desmethylimipramine on behavior in the forced swim test in peripubertal and adult rats.

Pechnick RN, Bresee CJ, Manalo CM, Poland RE.

Behav Pharmacol. 2008 Feb;19(1):81-4. doi: 10.1097/FBP.0b013e3282f3d07f.

21.

p21Cip1 restricts neuronal proliferation in the subgranular zone of the dentate gyrus of the hippocampus.

Pechnick RN, Zonis S, Wawrowsky K, Pourmorady J, Chesnokova V.

Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1358-63. doi: 10.1073/pnas.0711030105. Epub 2008 Jan 2.

22.

Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.

Liu X, Caggiula AR, Yee SK, Nobuta H, Sved AF, Pechnick RN, Poland RE.

Neuropsychopharmacology. 2007 Mar;32(3):710-8. Epub 2006 Jun 21.

23.

Developmental exposure to corticosterone: behavioral changes and differential effects on leukemia inhibitory factor (LIF) and corticotropin-releasing hormone (CRH) gene expression in the mouse.

Pechnick RN, Kariagina A, Hartvig E, Bresee CJ, Poland RE, Chesnokova VM.

Psychopharmacology (Berl). 2006 Mar;185(1):76-83. Epub 2006 Jan 14.

PMID:
16416158
24.
25.

Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats.

Liu X, Caggiula AR, Yee SK, Nobuta H, Poland RE, Pechnick RN.

Psychopharmacology (Berl). 2006 Mar;184(3-4):417-25. Epub 2005 Sep 15.

26.

Endotoxin exposure in utero increases ethanol consumption in adult male offspring.

Liu X, Lee JG, Yee SK, Bresee CJ, Poland RE, Pechnick RN.

Neuroreport. 2004 Jan 19;15(1):203-6.

PMID:
15106858
27.

Reduced immobility in the forced swim test in mice with a targeted deletion of the leukemia inhibitory factor (LIF) gene.

Pechnick RN, Chesnokova VM, Kariagina A, Price S, Bresee CJ, Poland RE.

Neuropsychopharmacology. 2004 Apr;29(4):770-6.

28.

Comparison of the effects of dextromethorphan, dextrorphan, and levorphanol on the hypothalamo-pituitary-adrenal axis.

Pechnick RN, Poland RE.

J Pharmacol Exp Ther. 2004 May;309(2):515-22. Epub 2004 Jan 23.

PMID:
14742749
29.

Self-administration of 5-iodo-A-85380, a beta2-selective nicotinic receptor ligand, by operantly trained rats.

Liu X, Koren AO, Yee SK, Pechnick RN, Poland RE, London ED.

Neuroreport. 2003 Aug 6;14(11):1503-5.

PMID:
12960773
30.

Effect of cigarette smoking on coumarin metabolism in humans.

Poland RE, Pechnick RN, Cloak CC, Wan YJ, Nuccio I, Lin KM.

Nicotine Tob Res. 2000 Nov;2(4):351-4.

PMID:
11197315
31.

Comparison of noncontingent versus contingent cocaine administration on plasma corticosterone levels in rats.

Galici R, Pechnick RN, Poland RE, France CP.

Eur J Pharmacol. 2000 Jan 3;387(1):59-62.

PMID:
10633161
32.

Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA.

Poland RE, Lutchmansingh P, McCracken JT, Zhao JP, Brammer GL, Grob CS, Boone KB, Pechnick RN.

Psychopharmacology (Berl). 1997 Jun;131(4):411-9.

PMID:
9226745
33.

1,3-Di-o-tolylguanidine (DTG) differentially affects acute and tonic formalin pain: antagonism by rimcazole.

Kest B, Mogil JS, Sternberg WF, Pechnick RN, Liebeskind JC.

Pharmacol Biochem Behav. 1995 Sep;52(1):175-8.

PMID:
7501662
34.

Antinociception following 1,3,-di-o-tolylguanidine, a selective sigma receptor ligand.

Kest B, Mogil JS, Sternberg WF, Pechnick RN, Liebeskind JC.

Pharmacol Biochem Behav. 1995 Apr;50(4):587-92.

PMID:
7617705
35.
36.
37.

Haloperidol increases pain behavior following peripheral tissue injury.

Kest B, Mogil JS, Sternberg WF, Pechnick RN, Liebeskind J.

Proc West Pharmacol Soc. 1994;37:89-90. No abstract available.

PMID:
7984683
38.

Effects of opioids on the hypothalamo-pituitary-adrenal axis.

Pechnick RN.

Annu Rev Pharmacol Toxicol. 1993;33:353-82. Review. No abstract available.

PMID:
8494344
39.

Interactive teaching, medical students, and substance abuse : university and community come together in a new endeavor.

Ungerleider JT, Pechnick RN, Wallbom AS, Siegel N, Fairbanks L, Ziedonis DM.

Acad Psychiatry. 1992 Sep;16(3):160-9. doi: 10.1007/BF03341386.

PMID:
24435350
41.

Binding affinity and antimuscarinic activity of sigma and phencyclidine receptor ligands.

Vargas HM, Pechnick RN.

Eur J Pharmacol. 1991 Mar 19;195(1):151-6.

PMID:
1648491
42.

Acute and chronic administration of cocaine produces hyperthermia in the rat.

Chung LL, Pechnick RN, Bova MP, George R.

Proc West Pharmacol Soc. 1991;34:27-8. No abstract available.

PMID:
1788296
43.

Determination of the loci of action of phencyclidine on the CNS-pituitary-adrenal axis.

Pechnick RN, Chun BM, George R, Hanada K, Poland RE.

J Pharmacol Exp Ther. 1990 Jul;254(1):344-9.

PMID:
2164101
44.
45.

Comparison of the effects of the acute administration of dexoxadrol, levoxadrol, MK-801 and phencyclidine on body temperature in the rat.

Pechnick RN, Wong CA, George R, Thurkauf A, Jacobson AE, Rice KC.

Neuropharmacology. 1989 Aug;28(8):829-35.

PMID:
2674766
47.

Naloxone does not produce withdrawal hypothermia in chronically phencyclidine-treated rats.

Pechnick RN, George R.

Eur J Pharmacol. 1989 Jul 18;166(2):295-8.

PMID:
2792194
48.

Pharmacokinetic and pharmacodynamic evaluation of phencyclidine and its decadeutero variant.

Cho AK, Hiramatsu M, Pechnick RN, Di Stefano E.

J Pharmacol Exp Ther. 1989 Jul;250(1):210-5.

PMID:
2746498

Supplemental Content

Loading ...
Support Center